Dysphagia for medication in Parkinson's disease.

Autor: Labeit B; Department of Neurology with Institute of Translational Neurology, University Hospital Muenster, Muenster, Germany. Bendixruven.Labeit@ukmuenster.de.; Institute for Biomagnetism and Biosignal Analysis, University Hospital Muenster, Muenster, Germany. Bendixruven.Labeit@ukmuenster.de., Berkovich E; Clexio Biosciences LTD, Jerusalem, Israel., Claus I; Department of Neurology with Institute of Translational Neurology, University Hospital Muenster, Muenster, Germany., Roderigo M; Department of Neurology with Institute of Translational Neurology, University Hospital Muenster, Muenster, Germany., Schwake AL; Department of Neurology with Institute of Translational Neurology, University Hospital Muenster, Muenster, Germany., Izgelov D; Clexio Biosciences LTD, Jerusalem, Israel., Mimrod D; Clexio Biosciences LTD, Jerusalem, Israel., Ahring S; Department of Neurology with Institute of Translational Neurology, University Hospital Muenster, Muenster, Germany., Oelenberg S; Department of Neurology with Institute of Translational Neurology, University Hospital Muenster, Muenster, Germany., Muhle P; Department of Neurology with Institute of Translational Neurology, University Hospital Muenster, Muenster, Germany.; Institute for Biomagnetism and Biosignal Analysis, University Hospital Muenster, Muenster, Germany., Zentsch V; Department of Neurology with Institute of Translational Neurology, University Hospital Muenster, Muenster, Germany., Wenninger F; Department of Neurology with Institute of Translational Neurology, University Hospital Muenster, Muenster, Germany., Suntrup-Krueger S; Department of Neurology with Institute of Translational Neurology, University Hospital Muenster, Muenster, Germany.; Institute for Biomagnetism and Biosignal Analysis, University Hospital Muenster, Muenster, Germany., Dziewas R; Department of Neurology and Neurorehabilitation, Klinikum Osnabrueck - Academic teaching hospital of the WWU Muenster, Osnabrueck, Germany., Warnecke T; Department of Neurology and Neurorehabilitation, Klinikum Osnabrueck - Academic teaching hospital of the WWU Muenster, Osnabrueck, Germany.

Publikováno v: NPJ Parkinson's disease [NPJ Parkinsons Dis] 2022 Nov 12; Vol. 8 (1), pp. 156. Date of Electronic Publication: 2022 Nov 12.

Pharmacokinetic investigation of synthetic cannabidiol oral formulations in healthy volunteers.

Autor: Izgelov D; Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, P.O. Box 12065, Jerusalem 91120, Israel., Davidson E; Department of Anesthesiology and Critical Care Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel., Barasch D; Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, P.O. Box 12065, Jerusalem 91120, Israel., Regev A; PureForm Biosciences, Los Angeles, CA, United States., Domb AJ; Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, P.O. Box 12065, Jerusalem 91120, Israel., Hoffman A; Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, P.O. Box 12065, Jerusalem 91120, Israel. Electronic address: amnonh@ekmd.huji.ac.il.

Publikováno v: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V [Eur J Pharm Biopharm] 2020 Sep; Vol. 154, pp. 108-115. Date of Electronic Publication: 2020 Jul 04.

Using the Absorption Cocktail Approach to Assess Differential Absorption Kinetics of Cannabidiol Administered in Lipid-Based Vehicles in Rats.

Autor: Izgelov D; Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, P.O. Box 12065, Jerusalem 91120, Israel., Regev A; PureForm Global Inc., 5700 Melrose Ave #208, Los Angeles, California 90038, United States., Domb AJ; Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, P.O. Box 12065, Jerusalem 91120, Israel., Hoffman A; Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, P.O. Box 12065, Jerusalem 91120, Israel.

Publikováno v: Molecular pharmaceutics [Mol Pharm] 2020 Jun 01; Vol. 17 (6), pp. 1979-1986. Date of Electronic Publication: 2020 May 13.

The effect of medium chain and long chain triglycerides incorporated in self-nano emulsifying drug delivery systems on oral absorption of cannabinoids in rats.

Autor: Izgelov D; Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, P.O. Box 12065, Jerusalem 91120, Israel., Shmoeli E; Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, P.O. Box 12065, Jerusalem 91120, Israel., Domb AJ; Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, P.O. Box 12065, Jerusalem 91120, Israel., Hoffman A; Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, P.O. Box 12065, Jerusalem 91120, Israel. Electronic address: amnonh@ekmd.huji.ac.il.

Publikováno v: International journal of pharmaceutics [Int J Pharm] 2020 Apr 30; Vol. 580, pp. 119201. Date of Electronic Publication: 2020 Mar 06.

Transformative solidification techniques for self-emulsifying drug delivery and its foresight in modern-day drug delivery.

Autor: Govindan, Induja¹, Rama, Annamalai¹, Kailas, Anjana A.¹, Hebbar, Srinivas¹, Naha, Anup¹ dranresearch@gmail.com

Publikováno v: Journal of Applied Pharmaceutical Science. Jul2024, Vol. 14 Issue 7, p001-013. 13p.